Press Releases

Featured Press Releases

Biotechnology Innovation Organization (BIO)…

WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…

Learn more

BIO Statement on Changes Announced to the U.S…

WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO) released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…

Learn more

BIO Statement on December 2025 ACIP Meeting

WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…

Learn more

BIO Applauds Bipartisan 2018 Farm Bill

December 11, 2018

Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the 2018 Farm Bill:

BIO Commends Signing of the United States-Mexico-Canada Agreement

November 30, 2018

Washington, D.C. (November 30, 2018) – Biotechnology Innovation Organization (BIO) President & CEO James C. Greenwood today issued the following statement on the United States-Mexico-Canada Agreement (USMCA):“The signing of today’s trade…

BIO Statement on EPA Finalizing RFS Volumes for 2019

November 30, 2018

Brent Erickson, Executive Vice President of the Biotechnology Innovation Organization’s (BIO) Industrial and Environmental Section, released the following statement today on final Renewable Fuel Standard (RFS) volumes for 2019 and the Biomass-Based…

BIO Applauds Inclusion of Pro-Growth Provisions in Tax and Oversight Legislation

November 28, 2018

“I applaud Chairman Brady and his colleagues on the House Ways & Means Committee for recognizing the unintended consequences faced by far too many small business innovators today due to NOL limitations."

21st Annual BIO CEO & Investor Conference Programming Announced

November 28, 2018

The Biotechnology Innovation Organization (BIO) today announced preliminary programming for the upcoming BIO CEO & Investor Conference to be held February 11-12, 2019 in New York City. Program lineup covers policy, investment, innovation and patient…

BIO Statement on Unsubstantiated Reports of Heritable Human Genome Editing Experiments in China

November 28, 2018

The Biotechnology Innovation Organization (BIO) issued the following statement regarding unsubstantiated reports this week of experiments involving heritable human genome editing in China.

BIO Welcomes 21 New Companies to Industrial & Environmental Section

November 28, 2018

The Biotechnology Innovation Organization today announced 21 companies have joined the Industrial & Environmental Section over the past year. BIO will work closely with these diverse new members as it continues to lead advocacy efforts that…

BIO Statement on Proposed Changes to Medicare Advantage and Part D Plans

November 26, 2018

“Today’s proposed rule to roll back critical protections afforded to some of America’s sickest and most vulnerable Medicare beneficiaries would, if adopted, severely limit seniors’ access to the drugs most appropriate for them, and is yet another…

New Report Shows Global Link Between Pro-Innovation Policies and Biotech Advances

November 19, 2018

Washington, D.C. (November 19, 2018) – A study released today highlights strategies, policies and best practices that have been successful in creating an environment in which biotechnology innovation can flourish around the world.The fifth edition…

BIO Releases Third Report in a Series on the State of Innovation in Highly Prevalent Chronic Diseases

November 15, 2018

Washington, DC (October 26, 2018) – Today, the Biotechnology Innovation Organization (BIO) released a new report, The State of Innovation in Highly Prevalent Chronic Diseases: Volume III Type 2 Diabetes and Obesity Therapeutics, the third in a…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.